BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 19513557)

  • 1. MicroRNA profiling of human kidney cancer subtypes.
    Petillo D; Kort EJ; Anema J; Furge KA; Yang XJ; Teh BT
    Int J Oncol; 2009 Jul; 35(1):109-14. PubMed ID: 19513557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
    Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
    Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA expression profiling of Xp11 renal cell carcinoma.
    Marchionni L; Hayashi M; Guida E; Ooki A; Munari E; Jabboure FJ; Dinalankara W; Raza A; Netto GJ; Hoque MO; Argani P
    Hum Pathol; 2017 Sep; 67():18-29. PubMed ID: 28411178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

  • 5. Messenger RNA expression ratios among four genes predict subtypes of renal cell carcinoma and distinguish oncocytoma from carcinoma.
    Chen YT; Tu JJ; Kao J; Zhou XK; Mazumdar M
    Clin Cancer Res; 2005 Sep; 11(18):6558-66. PubMed ID: 16166433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
    Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
    Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accurate molecular classification of kidney cancer subtypes using microRNA signature.
    Youssef YM; White NM; Grigull J; Krizova A; Samy C; Mejia-Guerrero S; Evans A; Yousef GM
    Eur Urol; 2011 May; 59(5):721-30. PubMed ID: 21272993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA profiling in renal carcinoma suggest the existence of a group of pro-angionenic tumors in localized clear cell renal carcinoma.
    Trilla-Fuertes L; Miranda N; Castellano D; López-Vacas R; Farfán Tello CA; de Velasco G; Villacampa F; López-Camacho E; Prado-Vázquez G; Zapater-Moros A; Espinosa E; Fresno Vara JÁ; Pinto Á; Gámez-Pozo A
    PLoS One; 2020; 15(2):e0229075. PubMed ID: 32109249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
    Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
    J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into the biology of renal cell carcinoma.
    Li L; Kaelin WG
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):667-86. PubMed ID: 21763962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers.
    Young AN; Amin MB; Moreno CS; Lim SD; Cohen C; Petros JA; Marshall FF; Neish AS
    Am J Pathol; 2001 May; 158(5):1639-51. PubMed ID: 11337362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.
    Durinck S; Stawiski EW; Pavía-Jiménez A; Modrusan Z; Kapur P; Jaiswal BS; Zhang N; Toffessi-Tcheuyap V; Nguyen TT; Pahuja KB; Chen YJ; Saleem S; Chaudhuri S; Heldens S; Jackson M; Peña-Llopis S; Guillory J; Toy K; Ha C; Harris CJ; Holloman E; Hill HM; Stinson J; Rivers CS; Janakiraman V; Wang W; Kinch LN; Grishin NV; Haverty PM; Chow B; Gehring JS; Reeder J; Pau G; Wu TD; Margulis V; Lotan Y; Sagalowsky A; Pedrosa I; de Sauvage FJ; Brugarolas J; Seshagiri S
    Nat Genet; 2015 Jan; 47(1):13-21. PubMed ID: 25401301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma.
    Sukov WR; Ketterling RP; Lager DJ; Carlson AW; Sinnwell JP; Chow GK; Jenkins RB; Cheville JC
    Hum Pathol; 2009 Sep; 40(9):1296-303. PubMed ID: 19386349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes.
    Rohan S; Tu JJ; Kao J; Mukherjee P; Campagne F; Zhou XK; Hyjek E; Alonso MA; Chen YT
    Clin Cancer Res; 2006 Dec; 12(23):6937-45. PubMed ID: 17145811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA 15a, inversely correlated to PKCα, is a potential marker to differentiate between benign and malignant renal tumors in biopsy and urine samples.
    von Brandenstein M; Pandarakalam JJ; Kroon L; Loeser H; Herden J; Braun G; Wendland K; Dienes HP; Engelmann U; Fries JW
    Am J Pathol; 2012 May; 180(5):1787-97. PubMed ID: 22429968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
    Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ
    Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary renal cell carcinoma within a renal oncocytoma: case report of an incidental finding of a tumour within a tumour.
    Rowsell C; Fleshner N; Marrano P; Squire J; Evans A
    J Clin Pathol; 2007 Apr; 60(4):426-8. PubMed ID: 17405978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA methylation profiling distinguishes histological subtypes of renal cell carcinoma.
    Slater AA; Alokail M; Gentle D; Yao M; Kovacs G; Maher ER; Latif F
    Epigenetics; 2013 Mar; 8(3):252-67. PubMed ID: 23428843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of kidney cancer: association of hyaluronic acid family with histological subtypes and metastasis.
    Chi A; Shirodkar SP; Escudero DO; Ekwenna OO; Yates TJ; Ayyathurai R; Garcia-Roig M; Gahan JC; Manoharan M; Bird VG; Lokeshwar VB
    Cancer; 2012 May; 118(9):2394-402. PubMed ID: 21887686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular subclassification of kidney tumors and the discovery of new diagnostic markers.
    Takahashi M; Yang XJ; Sugimura J; Backdahl J; Tretiakova M; Qian CN; Gray SG; Knapp R; Anema J; Kahnoski R; Nicol D; Vogelzang NJ; Furge KA; Kanayama H; Kagawa S; Teh BT
    Oncogene; 2003 Oct; 22(43):6810-8. PubMed ID: 14555994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.